Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Accumulated Depreciation & Amortization (2016 - 2026)

Avanos Medical's Accumulated Depreciation & Amortization history spans 13 years, with the latest figure at $38.9 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 14.51% to $38.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $38.9 million, a 14.51% decrease, with the full-year FY2025 number at $38.9 million, down 14.51% from a year prior.
  • Accumulated Depreciation & Amortization hit $38.9 million in Q4 2025 for Avanos Medical, up from $29.0 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for AVNS hit a ceiling of $47.7 million in Q4 2022 and a floor of $9.6 million in Q1 2025.
  • Historically, Accumulated Depreciation & Amortization has averaged $27.0 million across 5 years, with a median of $26.2 million in 2021.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: grew 24.54% in 2022 and later dropped 15.79% in 2025.
  • Tracing AVNS's Accumulated Depreciation & Amortization over 5 years: stood at $38.3 million in 2021, then rose by 24.54% to $47.7 million in 2022, then dropped by 3.35% to $46.1 million in 2023, then dropped by 1.3% to $45.5 million in 2024, then decreased by 14.51% to $38.9 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for AVNS at $38.9 million in Q4 2025, $29.0 million in Q3 2025, and $19.6 million in Q2 2025.